微RNA与非酒精性脂肪性肝病
被引量：3
Roles of microRNAs in non-alcoholic fatty liver disease
摘要
@@
出处
《中华肝脏病杂志》
CAS
CSCD
北大核心
2014年第6期-,共3页
Chinese Journal of Hepatology
基金
国家自然科学基金，国家高技术研究发展计划，重大科学仪器研究专项
同被引文献57
-
1Akihiko Osaki,Tomoyuki Kubota,Takeshi Suda,Masato Igarashi,Keisuke Nagasaki,Atsunori Tsuchiya,Masahiko Yano,Yasushi Tamura,Masaaki Takamura,Hirokazu Kawai,Satoshi Yamagiwa,Toru Kikuchi,Minoru Nomoto,Yutaka Aoyagi.Shear wave velocity is a useful marker for managing nonalcoholic steatohepatitis[J].World Journal of Gastroenterology,2010,16(23):2918-2925. 被引量：30
-
2Zeynel Abidin Ozturk,Abdurrahman Kadayifci.Insulin sensitizers for the treatment of non-alcoholic fatty liver disease[J].World Journal of Hepatology,2014,6(4):199-206. 被引量：14
-
3Cohen JC, Horton JD, Hobbs HH. Human fatty liver disease: old questions and new insights. Science 2011; 332:1519-1523 [PMID: 21700865 DOI: 10.1126/science.1204265]. 被引量：1
-
4Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999; 116:1413-1419 [PMID: 10348825 DOI: 10.1016/ S0016-5085(99) 70506-8]. 被引量：1
-
5Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005; 42:44-52 [PMID: 15895401 DOI: 10.1002/ hep.20734]. 被引量：1
-
6Margariti E, Deutsch M, Manolakopoulos S, Papatheodoridis GV. Non-alcoholic fatty liver disease may develop in individuals with normal body mass index. Ann Gastroentero12012; 25:45-51 [PMID: 24713801]. 被引量：1
-
7Fan JG, Farrell GC. Epidemiology of non- alcoholic fatty liver disease in China. J Hepatol 2009; 50:204-210 [PMID: 19014878 DOh 10.1016/ j.jhep.2008.10.010]. 被引量：1
-
8Amarapurkar DN, Hashimoto E, Lesmana LA, Sollano JD, Chen PJ, Goh KL. How common is non-alcoholic fatty liver disease in the Asia- Pacific region and are there local differences? ] Gastroenterol Hepatol 2007; 22:788-793 [PMID:17565631 DOI: 10.1111/j.1440-1746.2007.05042.x]. 被引量：1
-
9Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, Day C, Arcaro G. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007; 30:1212-1218 [PMID: 17277038 DOI: 10.2337/ dc06-2247]. 被引量：1
-
10Williamson RM, Price JF, Glancy S, Perry E, Nee LD, Hayes PC, Frier BM, Van Look LA, Johnston GI, Reynolds RM, Strachan MW. Prevalence of and risk factors for hepatic steatosis and nonalcoholic Fatty liver disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study. Diabetes Care 2011; 34:1139-1144 [PMID: 21478462 DOI: 10.2337/dc10-2229]. 被引量：1
引证文献3
-
1聂娇,李昌平.非酒精性脂肪性肝病中microRNA调控细胞凋亡的机制[J].世界华人消化杂志,2015,23(15):2389-2396. 被引量：1
-
2王鹭,朱琳,孙宇,董梁,赖成泽,孙辉.MicroRNA在非酒精性脂肪肝病变中的研究进展[J].国际遗传学杂志,2018,41(3):219-224. 被引量：2
-
3Alejandro Campos-Murguía,Astrid Ruiz-Margáin,JoséA González-Regueiro,Ricardo U Macías-Rodríguez.Clinical assessment and management of liver fibrosis in nonalcoholic fatty liver disease[J].World Journal of Gastroenterology,2020,26(39):5919-5943. 被引量：15
二级引证文献18
-
1张立亚,贾雯羽,许云云,周小明,杨锐,高聆,赵家军,陈文斌.小鼠亚临床甲状腺功能减退模型脂代谢相关microRNAs表达的变化[J].中华内分泌代谢杂志,2018,34(5):410-415. 被引量：7
-
2梁新妹,梁晨,李丹,李博,程茜茜.miR-34a与非酒精性单纯性脂肪肝发生发展关系的研究进展[J].中华保健医学杂志,2020,22(4):452-454. 被引量：2
-
3秦文,王晶波,王丽媛,卓勤,杨倬.微小RNA-29a通过沉默信息调节因子2相关酶类1基因调控肝细胞脂肪变性的机制[J].卫生研究,2021,50(2):284-288. 被引量：1
-
4贾丹丹,朱桂英,廖诗瑶,章慧,郭慧,杨莉莉,王长淼.《2020年欧洲临床营养和代谢学会实践指南:肝病的临床营养》解读[J].临床肝胆病杂志,2021,37(7):1553-1557. 被引量：1
-
5Alejandro Campos-Murguía,Berenice M Román-Calleja,JoséA González-Regueiro,Ivonne Hurtado-Díaz-de-León,Alberto Adrián Solís-Ortega,Nayelli C Flores-García,Ignacio García-Juárez,Astrid Ruiz-Margáin,Ricardo Ulises Macías-Rodríguez.Clinical perspectives,assessment,and mechanisms of metabolicassociated fatty liver disease in patients with COVID-19[J].World Journal of Gastroenterology,2021,27(33):5502-5519.
-
6詹惠珍,杜雅钦,王松姣.特利加压素联合腹水浓缩回输术治疗肝硬化并发顽固性腹水患者效果研究[J].实用肝脏病杂志,2022,25(3):395-398. 被引量：6
-
7刘芳,李建.非酒精性脂肪性肝脏疾病的疾病负担及医疗费用控制的研究进展[J].中国普外基础与临床杂志,2022,29(8):1115-1120. 被引量：2
-
8壮健,朱韦文,张超.基于LASSO回归的慢性乙型肝炎肝纤维化无创诊断模型的构建及验证[J].临床肝胆病杂志,2022,38(8):1790-1795. 被引量：5
-
9王建军,吕群,阮肇扬,戴一帆,黄章旦,王艺君,夏泽海.夜间间歇性缺氧对非酒精性脂肪性肝病患者肝纤维化进程的影响[J].全科医学临床与教育,2022,20(10):898-901.
-
10陈琳,汪玲,曾诚,杨春梅,李翠蓉,方煜,杨志俊.肝内胆管错构瘤在出入境人员中的超声诊断价值与漏误诊分析[J].口岸卫生控制,2022,27(4):39-41.
-
1张春梅（综述）,郭锡熔（审校）.Visfatin：一种新的脂肪细胞因子[J].国际儿科学杂志,2007,34(2):115-117.
-
2冯文焕,袁雪雯,高彩霞,毕艳,沈山梅,李平,姜灿,陶俊贤,殷婷婷,朱大龙.非酒精性脂肪性肝病大鼠高脂饮食后改为普通饮食的实验观察[J].中国糖尿病杂志,2016,24(7):645-648. 被引量：3
-
3王咏波,陈璐璐,周慜.糖尿病大鼠胰岛脂质分解的变化及意义[J].中国糖尿病杂志,2010,18(7):539-542.
-
4季光,张莉.非酒精性脂肪性肝病（续一）-非酒精性脂肪性肝病发病机制进展[J].中国医师进修杂志,2010,33(1):1-3. 被引量：7
-
5邹玲玲,戴武,鲁红云,刘红,李玲玲,孙辽,谢丹红.胰高血糖素样肽-1对人脂肪干细胞增殖、成脂分化及脂代谢的影响[J].中国现代医学杂志,2015,25(28):1-6. 被引量：3
-
6周玲玲,林琼琼,周伶俐,祁旦巳,赵志光.姜黄素对非酒精性脂肪肝家兔血脂及肝组织PPAR-γ水平的影响[J].浙江中西医结合杂志,2012,22(1):7-10. 被引量：16
-
7芒果皮降血脂[J].中外女性健康,2012(12):45-45.
-
8王滢,李倩.脑利钠肽与糖脂代谢的关系[J].国际内分泌代谢杂志,2015,35(2):103-105. 被引量：3
-
9陈宗兰（摘译）.二甲双胍可通过抑制肝脏脂质合成预防肝癌的发生[J].中华糖尿病杂志,2012,4(6):384-384.
-
10罗学兵.芒果皮泡水可降低血脂[J].健康必读（健康新语）,2016,0(5):17-17.
